GeneDx Hldgs Q1 2024 Adj EPS $(0.33) Beats $(0.67) Estimate, Sales $62.422M Beat $49.463M Estimate

GeneDx Holdings Corp Ordinary Shares - Class A -2.42%

GeneDx Holdings Corp Ordinary Shares - Class A

WGS

31.83

-2.42%

GeneDx Hldgs (NASDAQ: WGS) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.67) by 50.75 percent. The company reported quarterly sales of $62.422 million which beat the analyst consensus estimate of $49.463 million by 26.20 percent. This is a 44.70 percent increase over sales of $43.139 million the same period last year.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via